Literature DB >> 2567429

Serological diagnosis of salmonella infections by enzyme immunoassay.

O Isomäki1, R Vuento, K Granfors.   

Abstract

An enzyme immunoassay (EIA) for the detection and measurement of serum IgM, IgG, and IgA antibodies to salmonella was developed with commercially available lipopolysaccharides (LPSs) of Salmonella typhimurium and S enteritidis combined as antigen. Of 130 sera from patients with culture-confirmed salmonella infections, 115 (88.5%) were positive in this assay. The classic Widal agglutination test was positive in only 50 (38.5%) cases. This EIA method offers a substantial advance in the serological diagnosis of acute salmonella infections; it detects antibodies to the salmonellae of groups B and D, which constitute about 70% of culture-positive cases of human salmonellosis. Antibodies to other salmonellae are also detected. This EIA is particularly valuable for the detection of salmonella antibodies during post-infectious complications when isolation of the organism is often no longer possible.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567429     DOI: 10.1016/s0140-6736(89)90124-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

1.  Clinical application of a dot blot test for diagnosis of enteric fever due to Salmonella enterica serovar typhi in patients with typhoid fever from Colombia and Peru.

Authors:  N Cardona-Castro; E Gotuzzo; M Rodriguez; H Guerra
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis.

Authors:  C Fendler; S Laitko; H Sörensen; C Gripenberg-Lerche; A Groh; J Uksila; K Granfors; J Braun; J Sieper
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

3.  Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis.

Authors:  T Yli-Kerttula; R Luukkainen; U Yli-Kerttula; T Möttönen; M Hakola; M Korpela; M Sanila; J Parviainen; J Uksila; R Vainionpää; A Toivanen
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

4.  Enterobacterial infection modulates major histocompatibility complex class I expression on mononuclear cells.

Authors:  J Kirveskari; Q He; M Leirisalo-Repo; O Mäki-Ikola; M Wuorela; A Putto-Laurila; K Granfors
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

5.  Infectious background of patients with a history of acute anterior uveitis.

Authors:  M Huhtinen; K Laasila; K Granfors; M Puolakkainen; I Seppälä; L Laasonen; H Repo; A Karma; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

6.  Bacterial antibodies in ankylosing spondylitis.

Authors:  O Mäki-Ikola; K Lehtinen; K Granfors; R Vainionpää; P Toivanen
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

7.  Antibodies to arthritis-associated microbes in inflammatory joint diseases.

Authors:  O Mäki-Ikola; M K Viljanen; S Tiitinen; P Toivanen; K Granfors
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

8.  Kinetics of the human antibody response against Salmonella enterica Serovars Enteritidis and Typhimurium determined by lipopolysaccharide enzyme-linked immunosorbent assay.

Authors:  Mette A Strid; Tine Dalby; Kåre Mølbak; Karen A Krogfelt
Journal:  Clin Vaccine Immunol       Date:  2007-02-28

9.  IgA antibodies in HLA-B27 associated acute anterior uveitis and ankylosing spondylitis.

Authors:  S H Sprenkels; J Uksila; R Vainionpää; P Toivanen; T E Feltkamp
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

10.  Seroprevalence of antibodies against Chlamydia trachomatis and enteropathogens and distance to the nearest water source among young children in the Amhara Region of Ethiopia.

Authors:  Kristen Aiemjoy; Solomon Aragie; Dionna M Wittberg; Zerihun Tadesse; E Kelly Callahan; Sarah Gwyn; Diana Martin; Jeremy D Keenan; Benjamin F Arnold
Journal:  PLoS Negl Trop Dis       Date:  2020-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.